Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

425 ARTÍCULOS , VIENDO DEL 91 AL 105

Traditional Ayurvedic and herbal remedies for Alzheimer's disease: from bench to bedside

Sharma R, Kuca K, Nepovimova E, Kabra A, Rao MM, Prajapati PK.

Expert Rev Neurother. 2019 May;19(5):359-374. doi: 10.1080/14737175.2019.1596803. Epub 2019 Apr 10.

ApoE4: an emerging therapeutic target for Alzheimer's disease

Safieh M, Korczyn AD, Michaelson DM.

BMC Med. 2019 Mar 20;17(1):64. doi: 10.1186/s12916-019-1299-4.

Bioavailability and Pharmaco-therapeutic Potential of Luteolin in Overcoming Alzheimer's Disease

Ali F, Siddique YH.

CNS Neurol Disord Drug Targets. 2019;18(5):352-365. doi: 10.2174/1871527318666190319141835.

The vexing complexity of the amyloidogenic pathway

Castro MA, Hadziselimovic A, Sanders CR.

Protein Sci. 2019 Jul;28(7):1177-1193. doi: 10.1002/pro.3606. Epub 2019 Apr 11.

Targeting Inflammatory Pathways in Alzheimer's Disease: A Focus on Natural Products and Phytomedicines

Sharman MJ, Verdile G, Kirubakaran S, Parenti C, Singh A, Watt G, Karl T, Chang D, Li CG, Münch G.

CNS Drugs. 2019 May;33(5):457-480. doi: 10.1007/s40263-019-00619-1.

Can magnesium reduce central neurodegeneration in Alzheimer's disease? Basic evidences and research needs

Toffa DH, Magnerou MA, Kassab A, Hassane Djibo F, Sow AD.

Neurochem Int. 2019 Jun;126:195-202. doi: 10.1016/j.neuint.2019.03.014. Epub 2019 Mar 22.

Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease

Pinheiro L, Faustino C.

Curr Alzheimer Res. 2019;16(5):418-452. doi: 10.2174/1567205016666190321163438.

Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer's disease

Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K.

Life Sci. 2019 May 1;224:109-119. doi: 10.1016/j.lfs.2019.03.055. Epub 2019 Mar 23.

Therapeutic targeting of nuclear receptors, liver X and retinoid X receptors, for Alzheimer's disease

Fitz NF, Nam KN, Koldamova R, Lefterov I.

Br J Pharmacol. 2019 Sep;176(18):3599-3610. doi: 10.1111/bph.14668. Epub 2019 May 11.

Current and Future Treatments in Alzheimer's Disease

Atri A.

Semin Neurol. 2019 Apr;39(2):227-240. doi: 10.1055/s-0039-1678581. Epub 2019 Mar 29.

Transition Metal Ion Interactions with Disordered Amyloid-β Peptides in the Pathogenesis of Alzheimer's Disease: Insights from Computational Chemistry Studies

Strodel B, Coskuner-Weber O.

J Chem Inf Model. 2019 May 28;59(5):1782-1805. doi: 10.1021/acs.jcim.8b00983. Epub 2019 Apr 15.

Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis

Thancharoen O, Limwattananon C, Waleekhachonloet O, Rattanachotphanit T, Limwattananon P, Limpawattana P.

Drugs Aging. 2019 May;36(5):435-452. doi: 10.1007/s40266-019-00648-x.

Race reporting and disparities in clinical trials on Alzheimer's disease: A systematic review

Canevelli M, Bruno G, Grande G, Quarata F, Raganato R, Remiddi F, Valletta M, Zaccaria V, Vanacore N, Cesari M.

Neurosci Biobehav Rev. 2019 Jun;101:122-128. doi: 10.1016/j.neubiorev.2019.03.020. Epub 2019 Apr 1.

Current Updates on the Regulation of Beta-Secretase Movement as a Potential Restorative Focus for Management of Alzheimer's Disease

Ahmad SS, Kamal MA.

Protein Pept Lett. 2019;26(8):579-587. doi: 10.2174/0929866526666190405125334.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias